The residue threonine 82 of DevR (DosR) is essential for DevR activation and function in Mycobacterium tuberculosis despite its atypical location

Journal of Bacteriology

Volumn 193, Issue 18, 2011, Pages 4849-4858

  Gautam, Uma Shankar ^a,b   Sikri, Kriti ^a   Tyagi, Jaya Sivaswami ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; MUTANT PROTEIN; PROTEIN DEVR; PROTEIN DOSR; REGULATOR PROTEIN; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HYPOXIA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULON;

AMINO ACID SUBSTITUTION; BACTERIAL PROTEINS; DNA FOOTPRINTING; DNA, BACTERIAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; IMMUNOBLOTTING; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; MYCOBACTERIUM TUBERCULOSIS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN KINASES; THREONINE;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 80052548122     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.05051-11     Document Type: Article

References (45)

1. Appleby, J. L., and R. B. Bourret. 1998. Proposed signal transduction role for conserved CheY residue Thr87, a member of the response regulator activesite quintet. J. Bacteriol. 180:3563-3569.
2. Bagchi, G., S. Chauhan, D. Sharma, and J. S. Tyagi. 2005. Transcription and autoregulation of the Rv3134c-devR-devS operon of Mycobacterium tuberculosis. Microbiology 151:4045-4053.
3. Baikalov, I., et al. 1996. Structure of the Escherichia coli response regulator NarL. Biochemistry 35:11053-11061.
4. Balazsi, G., A. P. Heath, L. Shi, and M. L. Gennaro. 2008. The temporal response of the Mycobacterium tuberculosis gene regulatory network during growth arrest. Mol. Syst. Biol. 4:225.
5. Birck, C., et al. 1999. Conformational changes induced by phosphorylation of the FixJ receiver domain. Structure 7:1505-1515.
6. Bourret, R. B. 2010. Receiver domain structure and function in response regulator proteins. Curr. Opin. Microbiol. 13:142-149.
7. Chauhan, A., et al. 2006. Mycobacterium tuberculosis cells growing in macrophages are filamentous and deficient in FtsZ rings. J. Bacteriol. 188:1856-1865.
8. Chauhan, S., and J. S. Tyagi. 2008. Cooperative binding of phosphorylated DevR to upstream sites is necessary and sufficient for activation of the Rv3134c-devRS operon in Mycobacterium tuberculosis: implication in the induction of DevR target genes. J. Bacteriol. 190:4301-4312.
9. Chauhan, S., and J. S. Tyagi. 2008. Interaction of DevR with multiple binding sites synergistically activates divergent transcription of narK2-Rv1738 genes in Mycobacterium tuberculosis. J. Bacteriol. 190:5394-5403.
10. Chauhan, S., and J. S. Tyagi. 2009. Powerful induction of divergent tgs1-Rv3131 genes in Mycobacterium tuberculosis is mediated by DevR interaction with a high-affinity site and an adjacent cryptic low-affinity site. J. Bacteriol. 191:6075-6081.
11. Chauhan, S., D. Sharma, A. Singh, A. Surolia, and J. S. Tyagi. 7 June 2011. Comprehensive insights into Mycobacterium tuberculosis DevR (DosR) regulon activation switch. Nucleic Acids Res. [Epub ahead of print.] doi: 10.1093/nar/gkr375.
12. Dasgupta, N., et al. 2000. Characterization of a two-component system, devR-devS, of Mycobacterium tuberculosis. Tuber. Lung Dis. 80:141-159.
13. Gautam, U. S., S. Chauhan, and J. S. Tyagi. 2011. Determinants outside the DevR C-terminal domain are essential for cooperativity and robust activation of dormancy genes in Mycobacterium tuberculosis. PLoS One 6:e16500.
14. Grange, J. M. 1992. The mystery of the mycobacterial 'persistor.' Tuber. Lung Dis. 73:249-251.
15. Gupta, R. K., T. S. Thakur, G. R. Desiraju, and J. S. Tyagi. 2009. Structurebased design of DevR inhibitor active against nonreplicating Mycobacterium tuberculosis. J. Med. Chem. 52:6324-6334.
16. Kumar, A., J. C. Toledo, R. P. Patel, J. R. Lancaster, Jr., and A. J. Steyn. 2007. Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proc. Natl. Acad. Sci. U. S. A. 104:11568-11573.
17. Kumar, A., et al. 2008. Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. J. Biol. Chem. 283: 18032-18039.
18. Lamichhane, G. 2010. Novel targets in M. tuberculosis: search for new drugs. Trends Mol. Med. 17:25-33.
19. Lewis, R. J., J. A. Brannigan, K. Muchova, I. Barak, and A. J. Wilkinson. 1999. Phosphorylated aspartate in the structure of a response regulator protein. J. Mol. Biol. 294:9-15.
20. Lin, W. J., et al. 2009. Threonine phosphorylation prevents promoter DNA binding of the Group B Streptococcus response regulator CovR. Mol. Microbiol. 71:1477-1495.
21. Majumdar, S. D., et al. 2010. Expression of DevR and DevR(N)-Aph proteins is associated with hypoxic adaptation defect and virulence attenuation of Mycobacterium tuberculosis. PLoS One 5:e9448.
22. Majumdar, S. D., et al. 2010. Ph.D. thesis. All India Institute of Medical Sciences, New Delhi, India.
23. Maris, A. E., et al. 2002. Dimerization allows DNA target site recognition by the NarL response regulator. Nat. Struct. Biol. 9:771-778.
24. Mattison, K., R. Oropeza, N. Byers, and L. J. Kenney. 2002. A phosphorylation site mutant of OmpR reveals different binding conformations at ompF and ompC. J. Mol. Biol. 315:497-511.
25. Milani, M., et al. 2005. An active-like structure in the unphosphorylated StyR response regulator suggests a phosphorylation-dependent allosteric activation mechanism. Structure 13:1289-1297.
26. Murphy, D. J., and J. R. Brown. 2007. Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. BMC Infect. Dis. 7:84.
27. Parish, T., et al. 2003. Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis. Infect. Immun. 71: 1134-1140.
28. Park, H. D., et al. 2003. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol. Microbiol. 48: 833-843.
29. Roberts, D. M., R. P. Liao, G. Wisedchaisri, W. G. Hol, and D. R. Sherman. 2004. Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. J. Biol. Chem. 279:23082-23087.
30. Robinson, V. L., D. R. Buckler, and A. M. Stock. 2000. A tale of two components: a novel kinase and a regulatory switch. Nat. Struct. Biol. 7:626-633.
31. Rodrigue, S., et al. 2007. Identification of mycobacterial sigma factor binding sites by chromatin immunoprecipitation assays. J. Bacteriol. 189: 1505-1513.
32. Saini, D. K., et al. 2004. DevR-DevS is a bona fide two-component system of Mycobacterium tuberculosis that is hypoxia-responsive in the absence of the DNA-binding domain of DevR. Microbiology 150:865-875.
33. Saini, D. K., V. Malhotra, and J. S. Tyagi. 2004. Cross talk between DevS sensor kinase homologue, Rv2027c, and DevR response regulator of Mycobacterium tuberculosis. FEBS Lett. 565:75-80.
34. Sherman, D. R., et al. 2001. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc. Natl. Acad. Sci. U. S. A. 98:7534-7539.
35. Shiloh, M. U., P. Manzanillo, and J. S. Cox. 2008. Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe 3:323-330.
36. Stead, W. W. 1967. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am. Rev. Respir. Dis. 95:729-745.
37. Stock, A. M., V. L. Robinson, and P. N. Goudreau. 2000. Two-component signal transduction. Annu. Rev. Biochem. 69:183-215.
38. Taneja, N. K., S. Dhingra, A. Mittal, M. Naresh, and J. S. Tyagi. 2010. Mycobacterium tuberculosis transcriptional adaptation, growth arrest and dormancy phenotype development is triggered by vitamin C. PLoS One 5:e10860.
39. Valdivia, R. H., A. E. Hromockyj, D. Monack, L. Ramakrishnan, and S. Falkow. 1996. Applications for green fluorescent protein (GFP) in the study of host-pathogen interactions. Gene 173:47-52.
40. Vohra, R., M. Gupta, R. Chaturvedi, and Y. Singh. 2006. Attack on the scourge of tuberculosis: patented drug targets. Recent Pat. Antiinfect. Drug Discov. 1:95-106.
41. Voskuil, M. I., et al. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198:705-713.
42. Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.
43. Wayne, L. G., and C. D. Sohaskey. 2001. Nonreplicating persistence of mycobacterium tuberculosis. Annu. Rev. Microbiol. 55:139-163.
44. Weinstein, M., A. F. Lois, E. K. Monson, G. S. Ditta, and D. R. Helinski. 1992. Isolation of phosphorylation-deficient mutants of the Rhizobium meliloti two-component regulatory protein, FixJ. Mol. Microbiol. 6:2041-2049.
45. Wisedchaisri, G., M. Wu, D. R. Sherman, and W. G. Hol. 2008. Crystal structures of the response regulator DosR from Mycobacterium tuberculosis suggest a helix rearrangement mechanism for phosphorylation activation. J. Mol. Biol. 378:227-242.